Patent ID: 11945812
Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 29:
30. The compound or salt according to claim 29, wherein
E is, Q1 is selected from the group consisting of —CH2—, —C(═O)—, —C(═O)NH— and —C(═O)N(C1-4alkyl)-;
RD is selected from the group consisting of hydrogen, halogen and C1-6alkyl;
RE and RF is each independently selected from the group consisting of Ra2 and Rb2;
Ra2 is selected from the group consisting of hydrogen and C1-6alkyl, wherein the C1-6alkyl, is optionally substituted with one or more, identical or different Rb2 and/or Rc2;
each Rb2 is independently selected from the group consisting of —ORc2 and —C(═O)NRc2Rc2;
each Rc2 is independently selected from the group consisting of C1-6alkyl and 3-11 membered heterocyclyl.